Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 68788-4060

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 68788-4060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rabeprazole Sodium Delayed-release Tablets 20mg (20mg Container 30tablets)

Available*

FDA Label Image

Structure (4d1e141f 24d6 41e0 A671 48ff69147297 01)

FDA Label Image

Figure 2 (4d1e141f 24d6 41e0 A671 48ff69147297 02)

This text provides data on mean daytime heartburn scores for two groups with different dosages of a medication (RAB 10mg and RAB 20mg). The study evaluates heartburn severity on a scale from 0 to 4, with 0 indicating none and 4 indicating very severe heartburn. The chart shows the mean scores over study days, allowing for a comparison of the efficacy of the two dosages in managing heartburn symptoms.*

FDA Label Image

Figure 3 (4d1e141f 24d6 41e0 A671 48ff69147297 03)

This text provides data on the mean nighttime heartburn scores for three different treatments: Placebo, RAB 10mg, and RAB 20mg. The scores are given for four different categories: Light, Moderate, Severe, and Very Severe. The information is presented visually in a chart format.*

FDA Label Image

Figure 4 (4d1e141f 24d6 41e0 A671 48ff69147297 04)

The text provides a chart showing the mean daytime heartburn scores for RAB-USA-3 with RAB 20mg. The scores range from 0 to 3, where 0 represents "None" and 3 indicates the highest severity of heartburn. This data can be used for evaluating the effectiveness of the 20mg dose of RAB in managing daytime heartburn symptoms.*

FDA Label Image

Figure 5 (4d1e141f 24d6 41e0 A671 48ff69147297 05)

This document provides information on the mean nighttime heartburn scores for a study comparing a placebo group (n=56) with a group taking RAB (Rabeprazole) 20mg (n=53). The scores are categorized from 0 (no heartburn) to 4 (very severe heartburn). The data is grouped by study day to evaluate the effectiveness of the treatment.*

FDA Label Image

Logo (4d1e141f 24d6 41e0 A671 48ff69147297 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.